SCHEMBL24011335

SCHEMBL24011335

COc1ccc(CNC(=O)N[C@H]2CC[C@@H](C(=O)N3CCCc4ccccc43)CC2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ NPC1 O15118 1/20 0.57
▸ ALDH1A1 P00352 4/20 0.56
▸ THRB P10828 1/20 0.55
▸ POLB P06746 1/20 0.52
▸ MAPT P10636 4/20 0.52
▸ TSHR P16473 3/20 0.51
▸ LMNA P02545 1/20 0.51
▸ MCHR1 Q99705 2/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ HRH3 Q9Y5N1 1/20 0.49
▸ PDE4B Q07343 1/20 0.49
▸ PDE4D Q08499 1/20 0.49
▸ TP53 P04637 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24011331 1.00 RAB9A (0.57) RAB9ASMN1; SMN2NPC1ALDH1A1THRB
SCHEMBL24011484 1.00 RAB9A (0.57) RAB9ASMN1; SMN2NPC1ALDH1A1THRB
SCHEMBL24011432 0.94 MAPT (0.57) RAB9ASMN1; SMN2NPC1ALDH1A1THRB
SCHEMBL26633720 0.89 ALDH1A1 (0.54) RAB9ASMN1; SMN2NPC1ALDH1A1THRB
SCHEMBL26764371 0.89 ALDH1A1 (0.54) RAB9ASMN1; SMN2NPC1ALDH1A1THRB
SCHEMBL30288091 0.89 ALDH1A1 (0.54) RAB9ASMN1; SMN2NPC1ALDH1A1THRB
SCHEMBL24011392 0.89 SMN1; SMN2 (0.54) RAB9ASMN1; SMN2NPC1ALDH1A1THRB
SCHEMBL24011658 0.89 NPC1 (0.54) RAB9ASMN1; SMN2NPC1ALDH1A1THRB
SCHEMBL24011040 0.89 LMNA (0.55) RAB9ASMN1; SMN2NPC1ALDH1A1POLB
SCHEMBL24011501 0.88 RAB9A (0.53) RAB9ASMN1; SMN2NPC1ALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
WO-2021226276-A2 NAMPT MODULATORS CYTOKINETICS, INC. (US) 2021-11-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT RAB9A 814/4885SMN1; SMN2 610/4885NPC1 128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback